ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04744	Phototransduction	12/163	36/7206	9.36062130581e-12
ko04080	Neuroactive ligand-receptor interaction	35/163	423/7206	9.79499875946e-12
ko05033	Nicotine addiction	12/163	56/7206	2.82339554006e-09
ko05032	Morphine addiction	15/163	110/7206	1.99500752824e-08
ko04727	GABAergic synapse	14/163	110/7206	1.47118803234e-07
ko04742	Taste transduction	10/163	61/7206	8.88470134303e-07
ko04723	Retrograde endocannabinoid signaling	16/163	175/7206	1.82921920917e-06
ko04724	Glutamatergic synapse	12/163	152/7206	0.00015738969121
ko00230	Purine metabolism	12/163	194/7206	0.00143099915024
ko04024	cAMP signaling pathway	15/163	279/7206	0.00155890813705
ko04740	Olfactory transduction	7/163	80/7206	0.00211740283224
ko04713	Circadian entrainment	9/163	136/7206	0.00358286626307
ko04911	Insulin secretion	8/163	117/7206	0.00488008780155
ko00534	Glycosaminoglycan biosynthesis - heparan sulfate / heparin	3/163	26/7206	0.0201719370666
ko05030	Cocaine addiction	5/163	73/7206	0.0243488337971
ko05200	Pathways in cancer	4/163	492/7206	0.0259204809505
ko00512	Mucin type O-glycan biosynthesis	3/163	29/7206	0.0269912837436
ko04725	Cholinergic synapse	8/163	160/7206	0.0283747150583
ko04022	cGMP-PKG signaling pathway	10/163	216/7206	0.0309885399185
ko04925	Aldosterone synthesis and secretion	6/163	105/7206	0.0313515300077
ko05205	Proteoglycans in cancer	1/163	271/7206	0.0331377453912
ko04721	Synaptic vesicle cycle	5/163	80/7206	0.0344066636602
ko04151	PI3K-Akt signaling pathway	3/163	390/7206	0.035287655185